Pharma

Your Article Summary

See Latest Articles

Why Prostate Cancer Patients Fail Hormone Deprivation Therapy; Johns Hopkins Scientists Identify Receptor Type That Makes Cancer Cells Resistant to Therapy, More Aggressive
PharmExec, 01/12/09

The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy.

Today in Physician/Patient Trends...keeping you current

Receive free subspecialty "5-minute updates" via email

Predicting age at onset of menopause: Testing the "adaptive onset" hypothesis
Maturitas, 11/11/09

Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09

Urinary Diversion Trends at a High Volume, Single American Tertiary Care Center
The Journal of Urology, 11/02/09

See All of Physician/Patient Trends